Mark Clemons
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Paul Edward Goss (2 shared papers)Karen A. Gelmon (2 shared papers)Amit M. Oza (2 shared papers)Kenneth D. Swenerton (1 shared paper)James Carmichael (1 shared paper)André Robidoux (1 shared paper)Euan Macpherson (1 shared paper)Hal W. Hirte (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (5 papers)Clinical Breast Cancer (3 papers)Journal of Clinical Oncology (3 papers)Supportive Care in Cancer (3 papers)The Lancet Oncology (2 papers)
- Partner nations
- CanadaNew ZealandUnited Kingdom
In The Last Decade
Mark Clemons
28 papers receiving 3.6k citations
Mark Clemons's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 2.0k
- Cancer Research 533
- Reproductive Medicine 290
- Genetics 721
- Pulmonary and Respiratory Medicine 637
Countries citing papers authored by Mark Clemons
This map shows the geographic impact of Mark Clemons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Clemons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Clemons more than expected).
Fields of papers citing papers by Mark Clemons
This network shows the impact of papers produced by Mark Clemons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Clemons. The network helps show where Mark Clemons may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Clemons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study Hit paper breakdown → | 2011 | 967 |
| 2 | Estrogen and the Risk of Breast Cancer Hit paper breakdown → | 2001 | 880 |
| 3 | 2009 | 391 | |
| 4 | 2003 | 310 | |
| 5 | 2008 | 199 | |
| 6 | 2007 | 172 | |
| 7 | 2006 | 116 | |
| 8 | 2009 | 79 | |
| 9 | 2013 | 79 | |
| 10 | 2007 | 69 | |
| 11 | 2009 | 61 | |
| 12 | 2009 | 60 | |
| 13 | 2008 | 58 | |
| 14 | 2009 | 50 | |
| 15 | 2002 | 34 | |
| 16 | 2007 | 29 | |
| 17 | 2006 | 28 | |
| 18 | 2007 | 27 | |
| 19 | 2011 | 27 | |
| 20 | 2007 | 24 |
About Mark Clemons
Mark Clemons is a scholar working on Oncology, Genetics, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 28 papers that have together received 3.7k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Cancer Treatment and Pharmacology (5 papers), Menopause: Health Impacts and Treatments (4 papers), Bone health and treatments (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cancer Risks and Factors (3 papers), Management of metastatic bone disease (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (533 citations), Reproductive Medicine (290 citations), Genetics (721 citations) and Pulmonary and Respiratory Medicine (637 citations). Mark Clemons has collaborated with scholars based in Canada, New Zealand and United Kingdom. Frequent co-authors include Paul Edward Goss, Karen A. Gelmon, Amit M. Oza, Kenneth D. Swenerton, James Carmichael, André Robidoux, Euan Macpherson, Hal W. Hirte, Rinat Yerushalmi and Katia Sonia Tonkin. Their work appears in journals such as Breast Cancer Research and Treatment, Clinical Breast Cancer, Journal of Clinical Oncology, Supportive Care in Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.